United States Antimony shares rise 8.77% in trading despite revenue outlook cut
Key Facts
United States Antimony shares rose 8.77% to $3.1000 during trading on 19 October 2026, according to prices displayed on Investing.com, as the company faces lower antimony selling prices and declining quarterly revenue. The gains came after the company cut its full-year revenue outlook despite an increase in antimony volumes sold in the second quarter. In October, Texas Capital Securities initiated coverage of the stock with a buy rating, according to a report published by the website. The firm set a price target of $9.50 per share in its coverage of the company. The initiation coincided with a period in which the company has both an existing supply contract for defense applications and a board-authorized common share repurchase program.
The company's filing with the U.S. Securities and Exchange Commission showed that revenue for the second quarter of 2026 totaled $7.9 million. Revenue had reached $10.5 million in the second quarter of 2025, putting the latest period's results below the year-earlier level. For the full year, the company lowered its expected revenue range to $60–75 million, according to an Investing.com report on the revised outlook. That range compares with a previous 2026 revenue target of $125 million, which the company had aimed to achieve before the cut. The annual outlook revision thus accompanied quarterly results showing a decline in revenue, even as antimony sales volumes rose during the same period.
According to the company's results presentation published by Investing.com, antimony volumes sold in the second quarter of 2026 rose 26% from the year-earlier period. Total volumes reached 428,425 pounds, an increase accompanied by a sharp decline in the average price the company realized on sales. The average antimony selling price fell 52% year on year to $13.70 per pound during the quarter. The increase in pounds sold was thus accompanied by a decline in realized prices, as the company recorded a drop in total quarterly revenue. The period's results combined an expansion in volumes sold with weaker selling prices, the two trends highlighted in the results presentation alongside the full-year outlook cut.
In its defense business, the company has a sole-source supply contract with the U.S. Defense Logistics Agency worth $245 million, according to Investing.com's report on a September delivery update. Defense applications for its products include the use of antimony trisulfide as a primer in ammunition. The company says it is the only producer in the Western Hemisphere of military-grade antimony ingots, according to the report on its update. It defines these ingots as having purity exceeding 99.6%, a description the company attributes to its military products. The U.S. Geological Survey explains the government's interest in the metal by stating that antimony is considered a critical mineral "primarily because of its use in military applications," placing it among supply security priorities.
On the capital front, the company's board authorized a program in August to repurchase its common shares, according to an announcement detailed by Investing.com. The authorization allows purchases of up to $100 million in shares, with that amount serving as the program's authorized ceiling. The program has no fixed expiration date requiring the company to complete it within a specified period, according to the announced terms. Those terms also allow the program to be modified, suspended or terminated at any time. The authorization forms part of the backdrop to the stock's moves, alongside weaker quarterly results, the cut to annual revenue expectations and the existing defense contract on which the company issued an update in September.
On trade, China's Ministry of Commerce set 27 November 2026 as the end date for the suspension of the implementation of the second paragraph of its announcement tightening controls on exports of dual-use items to the United States. The suspension concerns that paragraph of the announcement, which addresses exports destined for the U.S. market. The ministry said in the text of its decision that the paragraph's "implementation is suspended," specifying that the measure would remain in effect until the announced date. The decision comes in the context of Chinese controls on dual-use items, while military applications retain a central role in the U.S. classification of antimony as a critical mineral. The specified period for suspending the paragraph's implementation ends on 27 November 2026.